Vertex Pharmaceuticals
VRTX
VRTX
947 hedge funds and large institutions have $65.9B invested in Vertex Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 92 funds opening new positions, 403 increasing their positions, 319 reducing their positions, and 95 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $70.6B → $65.9B (-$4.67B)
15% less call options, than puts
Call options by funds: $237M | Put options by funds: $279M
26% less funds holding in top 10
Funds holding in top 10: 27 → 20 (-7)
Holders
947
Holding in Top 10
20
Calls
$237M
Puts
$279M
Top Buyers
| 1 | +$248M | |
| 2 | +$236M | |
| 3 | +$221M | |
| 4 |
Goldman Sachs
New York
|
+$148M |
| 5 |
HM
HealthCor Management
New York
|
+$91.6M |
Top Sellers
| 1 | -$307M | |
| 2 | -$225M | |
| 3 | -$220M | |
| 4 |
Renaissance Technologies
New York
|
-$156M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$121M |